(Reuters) – An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech COVID-19 vaccine for people over age 16, an important step after the vaccine gained full U.S. approval by the Food and Drug Administration last week.
(Reporting by Manas Mishra in Bengaluru; Editing by Leslie Adler)
